Opportunity Information: Apply for CDC RFA GH21 2153
This funding opportunity, titled "Advancing Comprehensive Community-Based HIV Services to Achieve Epidemic Control in Namibia under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR)," is a CDC cooperative agreement (Funding Opportunity Number: CDC RFA GH21 2153; CFDA: 93.067) designed to strengthen Namibia's progress toward HIV epidemic control in line with the country’s National Strategic Framework for HIV/AIDS and the national target of reaching epidemic control by 2030. The award is positioned as a partnership-style mechanism, meaning the selected recipient or recipients are expected not only to carry out services but also to work closely with CDC/PEPFAR through substantial involvement, including ongoing technical collaboration and technical assistance support.
Funding for Year 1 is projected at approximately $6,000,000 in total across the program, contingent on the availability of funds, with an expectation of up to two awards. Notably, the listed "Award Ceiling for Year 1" is $0, which typically signals that the agency is not setting a per-award maximum cap in the posted synopsis (rather than indicating there is no funding). Eligibility is described as unrestricted (open to any entity type, as long as it meets any additional eligibility conditions stated in the full announcement). The opportunity was posted by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH), with an original application deadline of March 23, 2021, by 11:59 p.m. ET for electronic submissions.
Programmatically, the core purpose is to implement and provide technical assistance for comprehensive, community-based HIV services across all fourteen regions of Namibia, explicitly spanning the UNAIDS 95-95-95 cascade. In practice, this means the work is meant to drive improvements across the full continuum: finding people living with HIV who do not yet know their status (first 95), rapidly linking those diagnosed to treatment (second 95), and ensuring sustained adherence and viral suppression through strong retention support (third 95). The announcement emphasizes targeted HIV case finding rather than broad, untargeted testing, implying an expectation of data-driven outreach and prioritization of populations and locations with the greatest unmet need and transmission risk.
A major service package area is index testing, where close contacts of people diagnosed with HIV are offered testing in a structured, ethical, and confidential manner. The recipient(s) are expected both to implement these services and to provide technical assistance, which suggests responsibilities such as setting up standard operating procedures, training and mentoring community and facility teams, strengthening referral networks, and ensuring quality and safeguards. Alongside testing and linkage, the opportunity stresses treatment support for clients on antiretroviral therapy (ART), including support groups and Community Adherence Groups (CAGs). These community models are intended to reduce barriers to staying on treatment, normalize long-term ART use, and improve retention and viral suppression, particularly in settings where distance, stigma, or competing daily demands can disrupt care.
Another central focus is defaulter tracing for ART patients who miss appointments, with the explicit goal of re-engaging them back into treatment and routine clinical monitoring. This component generally involves systematic identification of missed appointments, rapid outreach through community networks and communication channels, assessment of barriers (transport, stigma, side effects, mobility, work schedules), and facilitated return to care. The opportunity also includes a distinct maternal tracing and follow-up package tied to prevention of mother-to-child transmission and maternal-child health continuity. This includes enrolling pregnant women identified in the community into antenatal care (ANC), supporting mother-baby follow-ups for women living with HIV and their infants, and ensuring both mother and child receive timely testing, treatment when indicated, and are retained in care over time. The emphasis on mother-baby pair follow-up signals the program’s intent to close gaps after initial ANC entry, including postpartum drop-off, infant testing milestones, and sustained maternal ART adherence.
The NOFO also integrates community-based TB/HIV activities, reflecting the close relationship between HIV and tuberculosis outcomes. Recipients are expected to support tuberculosis preventive treatment (TPT) for eligible clients, promote or facilitate TB screening, and actively refer contacts of TB/HIV co-infected patients. In practical terms, this points to community-level education and symptom screening, adherence support for preventive regimens, coordination with clinical services for diagnostic evaluation, and contact investigation pathways that ensure people exposed to TB are not missed. By including TB/HIV in the community package, the program aims to reduce morbidity and mortality while improving overall HIV treatment outcomes, since TB remains a major driver of illness among people living with HIV.
Across all these components, the announcement underscores the expectation that approaches remain evidence-based and locally relevant, meaning the implementing partner(s) should use proven strategies but tailor them to Namibia’s epidemiology, health system realities, cultural context, and regional differences. Finally, the program notes that recipients should be available for emergency preparedness, suggesting that community service platforms and outreach systems may need to remain flexible and capable of adapting during disruptions such as outbreaks, natural disasters, or other public health emergencies that can interrupt routine HIV and TB services.Apply for CDC RFA GH21 2153
- The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Advancing Comprehensive Community-Based HIV Services to Achieve Epidemic Control in Namibia under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Jan 20, 2021.
- Applicants must submit their applications by Mar 23, 2021 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: Department of Health and Human Services, Centers for Disease Control - CGH
Browse more opportunities from the same category: Health
Next opportunity: Women Entrepreneurs Program
Previous opportunity: Next Generation Sequencing in Post Mortem Tissue from Patients with Parkinsons Disease (U01 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH21 2153
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH21 2153) also looked into and applied for these:
| Funding Opportunity |
|---|
| Bridging the Word Gap Research Network (BWG) Apply for HRSA 21 040 Funding Number: HRSA 21 040 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Money Follows the Person Rebalancing Demonstration Program - Capacity Building Apply for CMS 1LI 21 001 Funding Number: CMS 1LI 21 001 Agency: Department of Health and Human Services, Centers for Medicare Medicaid Services Category: Health Funding Amount: $5,000,000 |
| NIOSH Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed) Apply for PAR 21 148 Funding Number: PAR 21 148 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $20,000 |
| Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24) Apply for RFA OH 21 007 Funding Number: RFA OH 21 007 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $1,100,000 |
| The Microbicide 2021 Introduction and Access Project Apply for 7200AA21RFA00008 Funding Number: 7200AA21RFA00008 Agency: Agency for International Development Category: Health Funding Amount: $85,000,000 |
| President's Malaria Initiative Eliminate Malaria (PMI-EM) Activity Apply for 72048221RFA00002 Funding Number: 72048221RFA00002 Agency: Agency for International Development, Burma USAID - Rangoon Category: Health Funding Amount: $30,000,000 |
| Military Health System Research (MHSR) Apply for 22 DHA MHSR Funding Number: 22 DHA MHSR Agency: Department of Defense, Defense Health Agency Category: Health Funding Amount: $10,000,000 |
| Comprehensive Addiction and Recovery Act (CARA) Local Drug Crises Grants Apply for CDC RFA CE21 2103 Funding Number: CDC RFA CE21 2103 Agency: Department of Health and Human Services, Centers for Disease Control - NCIPC Category: Health Funding Amount: $50,000 |
| Service Delivery for HIV Prevention Apply for 72061121RFA00001 Funding Number: 72061121RFA00001 Agency: Agency for International Development, Zambia USAID-Lusaka Category: Health Funding Amount: $75,000,000 |
| Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation’s Health Apply for CDC RFA OT18 18020301SUPP21 Funding Number: CDC RFA OT18 18020301SUPP21 Agency: Department of Health and Human Services, Centers for Disease Control - OSTLTS Category: Health Funding Amount: $250,000 |
| High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed) Apply for PAR 21 126 Funding Number: PAR 21 126 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed) Apply for PAR 21 127 Funding Number: PAR 21 127 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $600,000 |
| Human Immunology Project Consortium (HIPC) Coordinating Center (U01 Clinical Trial Not Allowed) Apply for RFA AI 20 080 Funding Number: RFA AI 20 080 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $1,200,000 |
| Research Grants to Develop or Identify Effective Strategies to Prevent Overdose Involving Illicit Stimulants and Polysubstance Use Involving Stimulants Apply for RFA CE 21 002 Funding Number: RFA CE 21 002 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $725,000 |
| Underground Mine Evacuation Technologies and Human Factors Research Apply for RFA OH 21 006 Funding Number: RFA OH 21 006 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $1,000,000 |
| Promoting Population Health through Increased Capacity in Alcohol Epidemiology & the Prevention of Excessive Alcohol Use Apply for CDC RFA DP21 2105 Funding Number: CDC RFA DP21 2105 Agency: Department of Health and Human Services, Centers for Disease Control - NCCDPHP Category: Health Funding Amount: $600,000 |
| Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01) Clinical Trials Not Required Apply for RFA FD 22 001 Funding Number: RFA FD 22 001 Agency: Department of Health and Human Services, Food and Drug Administration Category: Health Funding Amount: $2,500,000 |
| Dental Faculty Loan Repayment Program Apply for HRSA 21 019 Funding Number: HRSA 21 019 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Screening, Brief Intervention, and Referral to Treatment Apply for TI 21 008 Funding Number: TI 21 008 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $995,000 |
| Strengthening the Dominican Republic's National Health Services (SNS) in Prevention, Treatment, Capacity and Quality of Strategic Information and Human Resources for Health Related to HIV, TB, STIs under PEPFAR Apply for CDC RFA GH21 2108 Funding Number: CDC RFA GH21 2108 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH21 2153", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.